Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone®

This publication has 35 references indexed in Scilit:

• Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
  European Journal of Immunology, 1997
• Anti‐myelin basic protein and anti‐proteolipid protein specific forms of multiple sclerosis
  Annals of Neurology, 1994
• Immunological Aspects of Demyelinating Diseases
  Annual Review of Immunology, 1992
• T Cells Responsive to Myelin Basic Protein in Patients with Multiple Sclerosis
  Science, 1990
• A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis
  New England Journal of Medicine, 1987
• Chemically Defined Antiviral Vaccines
  Annual Review of Microbiology, 1980
• Neuroimmunologic Diseases of Animals and Humans. The Joseph E. Smadel Memorial Lecture
  Clinical Infectious Diseases, 1979
• In vivo and in vitro immunological cross‐reactions between basic encephalitogen and synthetic basic polypeptides capable of suppressing experimental allergic encephalomyelitis
  European Journal of Immunology, 1973
• Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide
  European Journal of Immunology, 1971
• Basic encephalitogenic protein: A simplified purification on sulphoethyl‐sephadex
  FEBS Letters, 1970